FindTrial
Sign In

A randomized controlled study of blunt and slitting dilatation for PICC catheterization in patients with hematologic tumors

A randomized controlled study of blunt and slitting dilatation for PICC catheterization in patients with hematologic tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053868
Enrollment
Unknown
Registered
2021-12-01
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neoplastic hematologic disorder

Interventions

Control group:Sharpness skin
Intervention group:Blunt skin

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. PICC is planned to be placed as an infusion channel; 3. Clear awareness and able to communicate normally; 4. Informed consent of the patient or guardian.

Exclusion criteria

Exclusion criteria: 1. Those who need to stop the catheter placement if there is an abnormal situation during the catheter placement; 2. Those with other serious primary diseases or malignant tumors of the heart, liver, kidney, etc.; 3. Pregnant and lactating patients.

Design outcomes

Primary

MeasureTime frame
One-time sheathing success rate;The incidence of oozing;—

Secondary

MeasureTime frame
Scabbard completion time;Blood oozing volume 24 hours after intubation;—

Countries

China

Contacts

Public ContactWang Fang

Peking University First Hospital

790821418@qq.com+86 15901183794

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026